Linked Life Data

19697101

Source:http://linkedlifedata.com/resource/pubmed/id/19697101

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-11-6
pubmed:abstractText
Phosphodiesterase-5 (PDE-5) inhibitors have an established role in the treatment of erectile dysfunction, but there is increasing evidence that these drugs are effective also for the treatment of lower urinary tract symptoms and benign prostatic hyperplasia (BPH). The mechanism of action of PDE-5 inhibitors in the prostate, however, is poorly understood. It is conceivable that these drugs act by reducing the smooth muscle tone of the organ, but this effect could produce vascular changes as well. The aim of this study was to investigate whether administration of Tadalafil, a PDE-5 inhibitor, in patients with BPH produces haemodynamic changes in the prostate that can be assessed using contrast-enhanced US (CEUS).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1826-6983
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
114
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1106-14
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US.
pubmed:affiliation
UCO di Radiologia, Università di Trieste, Ospedale di Cattinara, Trieste, Italy. bertolot@units.it
pubmed:publicationType
Journal Article